CareDx (CDNA) Gains from Sales and Divestitures (2016 - 2019)

CareDx's (CDNA) quarterly Gains from Sales and Divestitures came in at $439704.0 in Q2 2019, up 58.76% quarter-over-quarter from $276954.0 in Q1 2019.

CareDx (CDNA) Gains from Sales and Divestitures (2016 - 2019) Analysis & Trends

CareDx has disclosed Gains from Sales and Divestitures across 3 years of filings, most recently posting $439704.0 for Q2 2019.

  • Gains from Sales and Divestitures for Q2 2019 came in at $439704.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2019 was $439704.0 (changed N/A YoY), and the FY2018 annual result was $272806.0, changed N/A from the prior year.
  • Gains from Sales and Divestitures came in at $439704.0 for Q2 2019 at CareDx, up from $276954.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $439704.0 in Q2 2019 to a low of $26550.0 in Q1 2016.
  • The 3-year median for Gains from Sales and Divestitures is $272806.0 (2018), against an average of $208512.8.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn
10 CareDx 1.17 Bn 979.60 Mn 87.33 Mn

Historic Data

Download Data
DateValue
Jun 30, 2019 439,704.00
Jun 30, 2019 439,704.00
Mar 31, 2019 276,954.00
Mar 31, 2019 276,954.00
Dec 31, 2018 272,806.00
Dec 31, 2018 272,806.00
Jun 30, 2016 26,550.00
Jun 30, 2016 26,550.00
Mar 31, 2016 26,550.00
Mar 31, 2016 26,550.00